| Dr Erik Lystad, MD | |
|
2600 E Pflugerville Pkwy Ste 100, Pflugerville, TX 78660-5999 | |
| (512) 654-6100 | |
| (512) 654-6101 |
| Full Name | Dr Erik Lystad |
|---|---|
| Gender | Male |
| Speciality | Undefined Physician Type (specify) |
| Experience | 13 Years |
| Location | 2600 E Pflugerville Pkwy Ste 100, Pflugerville, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740574581 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Longs Peak Hospital | Longmont, CO | Hospital |
| Vhs Harlingen Hospital Company Llc | Harlingen, TX | Hospital |
| Uchealth Broomfield Hospital | Broomfield, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Poudre Valley Medical Group Llc | 9638208549 | 1605 |
News Archive
InnaVirVax, a biopharmaceutical company dedicated to the development of therapeutic and diagnostic solutions in pathologies associated with immune dysregulation, declared today that it has obtained authorization from the French drug agency (AFSSAPS) to start a Phase I/IIa clinical study of its therapeutic vaccine VAC-3S for the treatment of HIV infections. This authorization intervenes only two years and half after the launching of InnaVirVax's activities.
World Congress of Cardiology Report - The Reduction of Atherothrombosis for Continued Health (REACH) Registry investigators have released preliminary two-year outcomes data from this international, observational study which shows high rates of atherothrombotic events on a worldwide basis.
University of Oregon scientists have identified brain cells vital to how zebrafish socialize. When the neurons are disabled, their orientation to one another breaks down in ways similar to socialization problems seen in humans with autism spectrum disorders and schizophrenia.
The Department of Health and Human Services says it will award $30 million in consumer assistance grants to help states and territories either establish or strengthen programs that provide direct services to patients related to their health insurance, Modern Healthcare reports.
› Verified 5 days ago
| Entity Name | Poudre Valley Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366763260 PECOS PAC ID: 9638208549 Enrollment ID: O20100602000122 |
News Archive
InnaVirVax, a biopharmaceutical company dedicated to the development of therapeutic and diagnostic solutions in pathologies associated with immune dysregulation, declared today that it has obtained authorization from the French drug agency (AFSSAPS) to start a Phase I/IIa clinical study of its therapeutic vaccine VAC-3S for the treatment of HIV infections. This authorization intervenes only two years and half after the launching of InnaVirVax's activities.
World Congress of Cardiology Report - The Reduction of Atherothrombosis for Continued Health (REACH) Registry investigators have released preliminary two-year outcomes data from this international, observational study which shows high rates of atherothrombotic events on a worldwide basis.
University of Oregon scientists have identified brain cells vital to how zebrafish socialize. When the neurons are disabled, their orientation to one another breaks down in ways similar to socialization problems seen in humans with autism spectrum disorders and schizophrenia.
The Department of Health and Human Services says it will award $30 million in consumer assistance grants to help states and territories either establish or strengthen programs that provide direct services to patients related to their health insurance, Modern Healthcare reports.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Erik Lystad, MD Po Box 844658, Dallas, TX 75284-4658 Ph: (254) 724-2111 | Dr Erik Lystad, MD 2600 E Pflugerville Pkwy Ste 100, Pflugerville, TX 78660-5999 Ph: (512) 654-6100 |
News Archive
InnaVirVax, a biopharmaceutical company dedicated to the development of therapeutic and diagnostic solutions in pathologies associated with immune dysregulation, declared today that it has obtained authorization from the French drug agency (AFSSAPS) to start a Phase I/IIa clinical study of its therapeutic vaccine VAC-3S for the treatment of HIV infections. This authorization intervenes only two years and half after the launching of InnaVirVax's activities.
World Congress of Cardiology Report - The Reduction of Atherothrombosis for Continued Health (REACH) Registry investigators have released preliminary two-year outcomes data from this international, observational study which shows high rates of atherothrombotic events on a worldwide basis.
University of Oregon scientists have identified brain cells vital to how zebrafish socialize. When the neurons are disabled, their orientation to one another breaks down in ways similar to socialization problems seen in humans with autism spectrum disorders and schizophrenia.
The Department of Health and Human Services says it will award $30 million in consumer assistance grants to help states and territories either establish or strengthen programs that provide direct services to patients related to their health insurance, Modern Healthcare reports.
› Verified 5 days ago
Vikash Patel, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1701 E Pflugerville Pkwy, Pflugerville, TX 78660 Phone: 512-259-6000 Fax: 512-260-6005 | |
Radha S Mahale, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1701 E Pflugerville Pkwy, Pflugerville, TX 78660 Phone: 512-259-6000 | |
Dr. Travis Michael Averitt, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2100 Autumn Slate Dr Ste 150, Pflugerville, TX 78660 Phone: 737-220-7200 Fax: 512-406-7339 | |
Dr. Sangeetha Mariappan, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2100 Autumn Slate Dr Ste 150, Pflugerville, TX 78660 Phone: 737-220-7200 | |
Dr. Thomas E Martens, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 18817 Heatherwilde Blvd, Ste 150, Pflugerville, TX 78660 Phone: 512-523-4878 Fax: 512-870-9770 | |
John Reagan Boyd, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 200 Heatherwilde Blvd, Pflugerville, TX 78660 Phone: 512-989-7400 Fax: 512-989-0753 | |
Juan Davila, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1821 Fm 685, Pflugerville, TX 78660 Phone: 512-988-5355 Fax: 512-323-0307 |